טוען...
Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
AIM: To investigate the effect and mechanism of action of erlotinib, an epidermal growth factor receptor (EGFR) small molecule tyrosine kinase inhibitor (TKI), in the human pancreatic cancer cell line BxPC-3 both in vitro and in vivo. METHODS: In vitro, human pancreatic cancer cell line BxPC-3 was e...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The WJG Press and Baishideng
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744159/ https://ncbi.nlm.nih.gov/pubmed/18803351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.5403 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|